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Four Ca(OH)2-containing pulp-capping medicaments were compared for their ef-
fects on protein synthesis in early subcultures of monkey- and human-pulpal fib-
roblasts. While protein synthesis, as well as DNA synthesis, was depressed by three
of the medicaments, the protein-synthetic rate in human-cell cultures in the pre-
sence of Life® rose to control levels when the medium was changed daily, but was
depressed when the medium was not changed. This suggests that serum proteins
play a protective role for pulpal tissues under inflammatory conditions, at least in
the case of Life®, allowing odontoblasts to differentiate and make dentinal matrix
without interference of either toxic components or excess alkalinity.
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The results of a large number of studies have
indicated that Ca(OH)2 either in aqueous mix
or in setting compounds promotes healing of
dental pulp-tissue exposures (Zander 1939,
Glass & Zander 1949, Nyborg 1955, Nyborg
1958, Stanley & Lundy 1972, Tronstad 1974,
Schroder 1978, Fitzgerald 1979, for review
see Baume & Holz 1981). This healing of the
pulp is often characterized by the formation of
hard tissue at the exposure site in addition to
the re-establishment of normal pulp-tissue
morphology.
The exact mechanism behind the anabolic
effect of Ca(OH)2 on the pulp is not clear. It
has long been interpreted that the healing of
the pulp, including the formation of new hard
tissue, is the result of the caustic action of the
agent. Solubilized Ca(OH)2 is highly alkaline
and produces superficial necrosis when placed
directly on exposed pulp tissue. This necrosis
is later often accompanied by the formation of
dentin-like hard tissue which separates the
pulp tissue from the necrotic zone and the
capping agent (Glass & Zander 1949, Nyborg
1955, Schroder 1973). Thus, it has been as-
sumed that the positive response of the pulp
to capping with Ca(OH)2 is the effect of the
induced necrosis (Granath 1981, Baume &
Holz 1981).
Recent studies have, however, de-
monstrated that new hard tissue may form
directly at the medicament interface without
being preceded by a zone of necrosis
(Tronstad 1974, Fitzgerald 1979). These
studies, respectively, used the Ca(OH)2-con-
taining medicaments, Dycal® and Life®.
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Fitzgerald (1979) observed, in addition, that
pulpal fibroblasts and endothelial cells, within
a few days of experimental wounding, mig-
rated into the wound area and lined up di-
rectly adjacent to the medicament before new
odontoblasts and mineralized tissue were dif-
ferentiated. This observation suggests that the
Ca(OH)2 in the agent used by this author
(Life®) only to a minor extent, if any, pro-
duced a stimulatory effect on the pulp. The
premise may exist that the reorganization of
the pulpal tissue observed, including mar-
shalled new odontoblasts, matrix formation,
and mineralization of this matrix, simply was
due to stimuli related to the inflammatory
process initiated by the experimental wound-
ing (Hanks & Smith 1978). In fact. Cox et al.
(1982) recently reported that healing of de-
ntal pulp exposures, following capping with
Life® or Dycal®, occurred as frequently in
teeth of monkeys with superficial inflammat-
ory lesions at the exposure site, initiated by a
24 h oral exposure before capping, as in teeth
with normal pulps immediately capped. It
seems unlikely that the capping agent, at least
during the initial phases of the healing pro-
cess, produced much stimulation of pulpal
cells across the zone of acute inflammation. It
seems reasonable to assume that the alkalinity
or any other stimuli of the Ca(OH)2 would
have been neutralized by the inflammatory
exudate released at the wound area. Hence,
healing of dental pulp-tissue exposures may
be the natural response of the pulp to any
form of irritation, whether mechanical,
chemical, or inflammatory, provided that the
insult remains within tolerable limits.
Not every capping agent containing
Ca(OH)2 is associated with proper healing of
pulpal exposures. For example, the effective-
ness of Hydrex® and MPC® to support dentin
bridging has been reported to be poor
(Phaneuf et al. 1968, Hirschfeld et al. 1972,
Pitt Ford 1979, Heys et al. 1981). The causes
of the reduced healing of the pulp to these
agents may be the effect of a long standing
toxicity.
The objective of the present study was to
use an artificial in vitro system to study the
effects of various Ca(OH)2-containing pulp-
capping medicaments upon protein metabo-
lism of isolated pulpal cells in the absence of
inflammation. The question was whether any
of these agents had a dramatic effect upon
protein synthesis, which might, thus, support
the view that they stimulate matrix formation
and dentin bridging. A secondary objective
was to determine whether serum components
might play a role in the stimulation of protein
synthesis by these Ca(OH)2-containing medi-
caments.
Material and methods
Four different medicaments containing
Ca(OH)2 (New Improved Dycal® from L. D.
Caulk Co., Milford, DE; Hydrex® and Life®
from Kerr Manufacturing Co., Romulus, MI;
and Calasept®, a non-setting Ca(OH)2-salt
preparation, Scania Lab, Knivsta, Sweden)
were mixed according to manufacturers' di-
rections and placed into plastic molds pro-
ducing discs approximately 1.5 x 7 mm and
weighing 94 mg apiece. These discs, except for
Calasept®, were hardened in a moist in-
cubator at 37°C for 10 min and, subsequently,
used within 1 h (immediate set) or after gas
sterilizing with ethylene oxide and degassing
for 5 days in sterile dishes (long term set).
These discs were then either floated in the
medium above the monolayer, or were sub-
merged, lightly touching the monolayer.
Primary monkey-pulp fibroblasts (pulpob-
lasts) were obtained from extracted molars
from young Macaca mulatta (Rhesus mon-
key), after cleaning the outside of the teeth
with 70% ethanol and cracking the teeth in
half. Pulpal tissue was removed with sterile
forceps from each tooth and minced. Small
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explants of this tissue 'were placed into
chicken-embryo extract (Grand Island
Biological Co., Grand Island, NY) and then
into drops of reconstituted CO2-treated chic-
ken plasma. Primary human-pulpoblasts cul-
tures were begun in the same way from non-
carious premolars taken from young patients
for orthodontic treatment. Primary cultures of
both cell types were grown to confluency in
the alpha formulation of minimum essential
medium (alpha-MEM; Grand Island Biologi-
cal Co., Grand Island, NY) with 10% heat-in-
activated fetal calf serum (FCS), glutamine
(300 |xg/ml), and penicillin/streptomycin (100
IU and 100 |ig/ml, respectively). Both types
of pulpoblast cultures often took 2-̂ 3 months
to develop dense primary cultures. These cells
were fibroblastic in morphology when grow-
ing on plastic. The medium was changed every
3 days. At confluency, these cells were sub-
cultured at 50,000 cells/cm'^ to 24-well plastic
dishes (Falcon 3008; Becton, Dickinson &
Co., Cockeysville, MD) in 1 ml of alpha-
MEM with appropriate levels of FCS.
Four experiments were performed in this
study. In the first experiment, the monkey cells
were used to compare the effects of the four
kinds of medicaments (either floating or sub-
merged) upon protein synthesis with continu-
ous labelling with tritiated leucine
(•^H-leucine; 3 ^Ci/ml; New England Nuclear
Corp., Boston, MA). Dishes containing ex-
perimental samples were maintained for 2, 6,
and 24 h in the presence of alpha-MEM and
10% FCS. When necessary, surface tension of
the medium was able to keep the discs floating
and centered in the dish.
In the second experiment, discs of each
medicament were placed in 24-well dishes of
freshly subcultured monkey-pulpal cells. The
pulpoblasts had been plated at the same den-
sity and with the same medium except that
20% FCS was used and the complete medium
was exchanged every 24 h. This was done to
determine the effects of higher levels of serum
proteins upon DNA synthesis. Three 24-weI]
dishes containing experimental and eontrol
wells were labelled with tritiated thymidine
(^H-TdR; 5 [xCi/ml; New England Nuclear
Corp., Boston, MA) 24 h before death. One
dish was harvested at 24 h, another at 48 h
and the last at 72 h after introduction of the
discs. Observation of the effects of the medi-
caments upon early growth (logarithmic)
permitted measurement without the interfer-
ence of contact inhibition.
In the third experiment, monkey-pulpoblast
subcultures, plated at 50,000 cells/cm^ in
alpha-MEM and 10% FCS, were allowed to
grow to confluency so that contact inhibition
would reduce their proliferative rate, and
their metabolic activity would be pushed to-
ward protein synthetic activity, especially of
secreted proteins. Therefore, experimental
discs and alpha-MEM medium with 20% FCS
were introduced after 3 days incubation. The
complete medium including 20% FCS was
changed each day after introduction of the
sample discs. As in the second experiment,
this medium exchange was introduced to
mimic the presence of increased amounts of
serum protein in inflammatory exudate.
^H-leucine was added in the medium 24 h
before death. The dishes were harvested at 1,
2, and 3 days after introduction of the discs.
The fourth experiment was similar to the
third experiment except that human pulpob-
lasts were used, and experimental dishes were
harvested at 1 and 7 days, the medium with
20% FCS being changed each 24 h. As a sec-
ond kind of control, the alpha-MEM/10%
FCS was allowed to remain in another set of
wells without change for the entire 7 days.
Twenty-four hours before death, the medium
was drawn off all wells. Media for a particular
medicament or control was pooled and •'H-
leucine was added. The respective media for
each medicament was then replaced back into
the wells. This protocol was used to determine
if daily changes of medium with 20% FCS
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were a major contributing factor for increased
synthesis of new proteins.
The 24-well dishes were stored frozen after
after rinsing each well twice with phos-
phate-buffered sahne (PBS). At the time of
analysis, cells in each well were broken up by
freeze-thawing four to six times in the pre-
sence of 250 \i\ of a 1:9 solution of 0.05%
Triton X-100 and 0.1 N NaOH. The contents
of the wells and one wash (PBS) were re-
moved to a polyethylene microcentrifuge tube
(1.5 ml; Fisher Scientific Co., Pittsburgh, PA)
and trichloroacetic acid was added to a final
concentration of 12.5%. The samples were
centrifuged at 15,000 x 6 for 15 min at 4°C.
In those samples incubated with ^^H-leucine,
the pellet was solubilized in 1 N NaOH and
protein determination was performed ac-
cording to Lowry et al. (1951). In those sam-
ples incubated with ^H-TdR, the pellets were
dried and prepared by the method of Puzas
and Goodman (1978). To each dried pellet,
100 [xl of diaminobenzoic acid (DABA, 2 M;
Aldrich Chemical Co., Milwaukee, WI), fol-
lowed by hydrolysis at 100°C for 30 min. Af-
ter addition of 4 ml of 0.6 N perchloric acid,
each sample was analyzed by a Turner Model
111 fluorometer for DNA. A 2 cm^ well from
a 24-well dish contained between 0.35 and
0.58 îg DNA.
For determination of radioactivity in the
samples utilized for protein determination,
300 [i\ of the NaOH-solubilized pellet was
placed into 7 ml liquid scintillation vials with 5
ml of aqueous counting scintillant (ACS;
Amersham Corp., Arhngton Heights, IL). For
DNA samples, 300 îl of the DABA hydroly-
sate was added to the liquid scintillation vials
with ACS. Readings were expressed as
CPM/^g protein or CPM/^ig DNA. Statistical
comparison of the samples utilized the Stu-
dent 't' test.
Results
For the most part, our model utilized small
discs of pulp-capping medicaments lying di-
rectly on top of the cell layer. While the effect
of the weight of the disc was minimal, as was
apparent when the no disc and Teflon disc
controls were compared (Figs. 1 and 5), it was
felt that this model might approximate to
some extent the direct-contact relationship
often observed between the Ca(OH)2-con-
taining medicament and the pulpal tissue from
which pulpoblasts develop into new odonto-
blasts and produce dentin matrix.
In the first experiment, discs of the pulp-
capping medicaments were gently placed over
monkey-pulpal pulpoblasts and were com-
pared at 2, 6, and 24 h of continuous labelling
with ^H-leucine for new protein. Fig. 1 shows
the relationship of immediate set, submerged
discs of the four pulp-capping medicaments to
control wells (no disc and Teflon discs). In 24
h, Hydrex® allowed synthesis of about 66% as
much new protein as produced in the control
wells; Life® allowed only 38%. Protein synth-
esis by the cells in the presence of Dycal® as
well as Calasept® (either in disc form or sus-
pended) was negligible.
This experiment was repeated three times
and the same rank-order relationship oc-
curred, whether the discs were floating or
submerged, and whether they were used im-
mediately after preparation or 5 days after
preparation (long term set; Fig. 2). Calasept®
was not used in all studies because the discs
did not set up like other medicaments, but
rather dried by dehydration. Consequently,
the discs frequently fell apart. Also, from Fig.
2 it can be seen that, in general, new protein
synthesis occurred at greater levels for a given
medicament if the sample discs were floating
rather than submerged on top of the cell layer.
At least for the floating sample discs, the sam-
ples which had set for 5 days (long-term set)
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allowed more new protein synthesis than the
samples which were used immediately.
It was also observed that the medium,
which contained a color indicator, remained
more alkaline in certain groups of samples
than in others. Therefore, pH readings of
samples with media were taken at the same
surface area;volume ratio (94 mg;l ml) over
48 h, with changes of medium plus 10% FCS
after 24 h (Fig. 3). The incubation conditions
were also the same, i.e., in a humid, 37°C oven
Fig. 1. Protein synthesis in wells of monkey pul-
poblast after 2, 6, and 24 h continuous labelling
with •'H-leucine, Quadruplicate wells contained
immediate set, submerged discs of Hydrex®, Life®,
Dycal®, Calasept® (Ca(OH)2 disc and Ca(OH)2
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Fig. 2. Protein synthesis after 24 h labelling of monkey pulpoblasts with ^H-leucine for three pulp-capping
medicaments.


















Fz'g. 3. pH values for wells with four pulp-capping
medicaments and no disc controls for a 48 h period,
with one change of medium plus 10% FCS at 24 h.
No cells present in any of the wells.
with a 5% CO2-95% air atmosphere.
Calasept® discs, which continued to break
down over this period initially gave the high-
est pH value. The 12-h pH value was 8.8 be-
cause this alpha-MEM medium contains both
a bicarbonate and phosphate buffer system.
Over the 48-h period, after one medium/FCS
change, the pH of the medium containing
Calasept® was reduced toward neutrality (7.8
at 24 h, 7.3 at 48 h). On the other hand, the
pH of Dycal®, which began at 7.7 at 12 h, rose
to 8.0 by 24 h. After changing the medium/
FCS, the pH was buffered back only to 7.8 by
48 h. The pH of Life® and Hydrex® began at
7.7 and 7.6, respectively, and dropped to 7.5
by 24 h. After the medium/FCS change, the
pH continued to drop to 7.3 by 48h. This pat-
tern of buffering is somewhat reflective of the
relative aqueous solubility of these four medi-
caments. The control wells maintained a pH
of 7.0 throughout the time period. At the end
of 48 h, a hard crystalline material had formed
in the center of the well containing Calasept®.
Further observations with a scanning electron
microscope and elemental analysis showed
orderly crystal formation associated with the
Dycal® and Calasept® discs (unpublished
data). These crystals were found to contain
calcium and phosphorus by elemental
analysis. Wells containing Life® discs con-
tained much smaller, amorphous crystals.
In the second experiment, the effects of
these medicaments upon the synthesis of new
DNA were assessed. The level of DNA in
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Fig. 4. DNA levels and 24-h DNA synthetic rates of
monkey pulpoblasts in quadruphcate wells with 1,
2, and 3 days exposure to discs of the four medica-
ments. Teflon, or no discs (controls). The medium
with 20% FCS was changed every 24 h and ̂ H-Tdr
was added for the last 24 h before harvest of the
cells.





















Fig. 5. Protein synthetic rates (24 h) in wells of monkey pulpoblasts (i
CALASEPT
») and human pulpoblasts with
• )and without ( ) daily changes of medium with 20% FCS, when exposed to the four medica-
ments. Teflon or no disc (controls).
discs averaged about 0.5 ^g. In Fig. 4, the
24-h ^H-TdR incorporation rate into new
DNA in control wells (no discs or Teflon
discs) peaked at 2 days, which probably re-
flects when the wells became confluent, and
then dropped off by 3 days. The levels of
newly synthesized DNA were lower for all the
pulp-capping medicaments than for the con-
trols. Although the standard errors were
small, the slight variation from one type of
medicament to another is probably not as sig-
nificant as the generally reduced DNA synth-
esis. Hydrex® showed a 2.5 fold decrease in
thymidine incorporation between the first and
second day (P<0.1) . For the other medica-
ments, the fairly wide standard error values
and 't' values suggest that there are no real
differences in the DNA synthetic rates be-
tween 1 and 3 days.
The results of the third and fourth experi-
ments are combined in Fig. 5 in order to com-
pare the protein synthesis of monkey and hu-
man cells in the presence of these medica-
ments. It can be seen that for control wells (no
discs or Teflon discs), monkey pulpoblasts
(Days 1-3) and human pulpoblasts (Days 1-7)
increased their rate of incorporation of
^H-leucine dramatically. For human pulpob-
lasts, if the medium with 20% FCS was not
changed daily, the protein synthetic rate was
depressed for all pulp-capping medicaments.
For the wells containing Life® discs, again
both monkey pulpoblasts and human pulpob-
lasts showed dramatic increases in 24-h rates
of new protein synthesis. Although the rate
for human cells with Life® discs was not quite
as high as the rate for control wells of human
cells with no discs, they were about the same
as control wells of human cells with Teflon
discs. Between 1 and 7 days, the increase in
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protein synthetic rate was the most dramatic
(21-fold) found with any of the pulp-capping
medicaments ( P < 0.001). Again, daily
changes of alpha-MEM with 20% FCS were
essential for this protein synthesis. The results
for Hydrex® discs were different in the two
experiments. Although monkey cells showed
an increasing new protein-synthetic rate over
the 3 day period, protein synthesis in the hu-
man cells dropped off dramatically over a 7
day period, as if the daily changes of FCS
made no difference or were not sufficient to
withstand the effects of Hydrex®. Finally, the
protein-synthetic rates in monkey- and
human-pulpal pulpoblasts in the presence of
Dycal® and Calasept® were similar, i.e., neg-
ligible. There was only minimal protein synth-
esis in the presence of either medicament,
which resembles the results of the first study,
at 3 days and 7 days, even with daily changes
of serum-rich medium.
Discussion
The present study showed that with early sub-
cultures of monkey pulpoblasts, the relative
ability of several pulp-capping medicaments
to support cellular protein synthesis is as fol-
lows: Controls > Hydrex® > Dycal® and
Calasept®. This was true for monkey-pulpo-
blast cultures through 3 days exposure to
these medicaments. This was also true for
human-pulpoblast cultures at 24 h after ex-
posure. However, for one medicament, Hyd-
rex®, the protein-synthetic rate in human pul-
poblasts was depressed, even with daily
changes of medium plus 20% FCS, almost as
much as when the medium was not changed.
Therefore, for human pulpoblasts, by 7 days,
the rank order of Life® and Hydrex® was re-
versed.
The findings in the present study parallel
some reports of direct pulp-capping tests with
Life® in monkeys (Figzgerald 1979, Heys et
al. 1981, Cox et al. 1982), and with Hydrex®
in humans (Phaneuf 1968), but not those with
Dycal® in monkeys (Heys et al. 1981) or in
humans (Stanley 1971). In vitro tests are usu-
ally much more sensitive to the detrimental
effects of materials on cellular metabolism
than are cells and tissues in situ. Since Hyd-
rex® is relatively insoluble, the reduced pro-
tein synthesis in our cultured human cells in
the presence of Hydrex® is probably related
more to toxic effects of the medicament than
to alkalinity. Likely candidates for the "fac-
tors" toxic to human pulpoblasts in our system
may be mineral oil or natural resin compo-
nents released from Hydrex® into the
medium. This may explain the poor in vivo
results obtained with this medicament
(Phaneuf 1968, Hirschfeld et al. 1972).
Likewise, Dycal® was extremely toxic to pro-
tein synthesis in our system for both human
and monkey pulpoblasts, confirming the
findings of Tronstad et al. (1978). Dycal®
contains a plasticizer, ethyl toluene sul-
fonamide, which is used as a "catalyst" (Pitt
Ford 1979). It has been suggested that the
release of this plasticizer is responsible for in-
creased cell-membrane permeability and
subsequent decreased cellular respiration in
cultured rat pulp-tissue (Jones 1979). Life®
also contains ethyl toluene sulfonamide (Emil
Jandourek, Kerr Manfacturing Company,
personal communication). However, it may be
released at different rates from Life® and
Dycal® because of the greater density of
Life®. Further, Dycal® is more soluble than
either Life® or Hydrex®, and the alkalinity is
not well buffered (Fig. 3). Therefore, toxin
concentration as well as alkalinity may be re-
sponsible for Dycal®'s effect upon both
species of pulpoblasts. Finally, the toxicity of
Calasept® in our system may be attributed to
the "localized alkalinity" caused by the sol-
ubility of this material. This alkalinity has
been associated with the superficial necrosis
produced in pulpal tissue (Nyborg 1958,
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Schroder 1973, Granath 1981). Conse-
quently, although it eventually permits hard
tissue formation irt vivo, it would not seem to
serve as well as a direct pulp-capping medi-
cament in which the Ca(OH)2 is less soluble.
Without daily changes of medium with 20%
FCS (which stimulated protein synthesis in
controls), the protein-synthetic rate in the
human cells was depressed for all of the
Ca(OH)2-containing medicaments over the 7
day period (Fig. 5). Clearly, factors in the
serum had a beneficial value for the cells, and
these factors were depleted with time in cul-
ture. Likewise, serum factors such as proteins
released from dilated, leaky capillaries may
play an important role in maintaining the
health of the pulpal tissue at the site of pulp
capping. Although we did not test mecha-
nisms by which daily changes of FCS aided
protein synthesis in our cell cultures, we may
speculate that at least three mechanisms may
be operative; (1) buffering of -t-H and - O H
ions by several buffer systems in serum
(Granath 1981), (2) serum peptide and hor-
mone stimulation (Mather & Sato 1979, Price
& Gregory 1982), (3) detoxification through
complexing to such proteins as albumin
globulins and fibrinogen (Fugisawa & Masuh-
ara 1981).
In the present study, the buffering capacity
of the medium/FCS was sufficient to reduce
the alkalinity of these incubating solutions
containing Life®, Hydrex® and Calasept®
samples toward neutrality between 12 and 24
h (Fig. 3). It was not adequate to keep the pH
from rising from 12 to 24 h in the incubating
solutions containing Dycal®. This resultant al-
kalinity within the first 24 h was probably re-
sponsible for the depressed DNA and protein
synthesis for Dycal® and Calasept®. For Life®,
after one change of medium/FCS at 24 h, the
pH of the medium was near neutrality by
48 h. Further, the protein-synthetic rate in
human cells at the end of 7 days of daily
medium/FCS changes was the same as that in
Teflon-disc control wells. Also, if the
medium/FCS were not changed daily, the
protein-synthetic rate for Life® discs de-
creased over the 7 day period. Consequently,
the new medium/FCS was protecting the hu-
man cells from some toxic substance in Life®.
Finally, our experimental model could not
discriminate between mechanisms responsible
for the protection given by the medium/FCS
against these protein synthesis-depressing ef-
fects, whether they occurred in Hydrex®,
Dycal® or Life®.
It was obvious that this in vitro model was
not suitable for Calasept®, since the discs
broke down and formed a suspension. This
medicament was highly soluble, producing a
pH of almost 9 in the buffered system at 12 h.
By 24 and 48 h, a crystallization reaction
occurred which was associated with a reduc-
tion of pH. While Ca(OH)2 may be responsi-
ble for the superficial zone of necrosis caused
in situ at the tissue interface, this crystalliza-
tion process may account for the limited ex-
posure of newly marshalled odontoblasts to
hydroxyl ions, so that they are able to synth-
esize a dentin matrix. While it has been shown
that Ca-I--I- from the Ca(OH)2 medicament
does not contribute to calcification of the
dentin bridge in dogs (Sciaky & Pizanti 1960),
it has also been suggested that an alkaline en-
vironment in the vicinity of the highly soluble
Ca(OH)2 may contribute to mineralization of
a tissue with a suitable matrix, the calcium and
phosphate ions coming from the blood supply.
Perhaps this crystallization on the surface of
the discs and early crystallization of necrotic,
non-matrix tissue represents the same
phenomenon, and this area of "dystrophic
calcification" forms a barrier, protecting the
odontoblasts from the highly alkaline and
lethal environment of Dycal® and Calasept®.
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